Real-World Study Looks at Use of Bezlotoxumab, FMT for CDI :

A single-center study suggests that FMT and bezlotoxumab ― two recommended therapies for recurrent C difficile infections ― are not commonly used in Spain, which doesn't appear to align with US practice.

Related Keywords

United States , Spain , Madrid , Spanish , Patricia Mun , David Johnson , American College Of Gastroenterology , Forum Infectious Diseases , University Hospital Gregorio Maran , Ferring Pharmaceuticals , Drug Administration , Eastern Virginia Medical School In Norfolk , General University Hospital Gregorio Maran , Open Forum Infectious , Eastern Virginia Medical School , Medscape Medical , American College , C Diff Infection , Clostridium Difficile Infection , Lostridium Difficile Associated Disease , C Diff Associated Disease , Biologic Therapy , Fecal Transplantation , Stool Transplant , Ecal Bacteriotherapy , Fecal Microbiota Transplantation , Mt , Microbiome , Hospitals , Antibiotics , Igecycline , Transplantation , Transplant , Antimicrobial Stewardship , Bowel Preparation , Colonoscopy , Europe , European , Us Fo ,